Spero Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
SPRO on Nasdaq
Industry
Pharmaceutical Preparations
Location
675 Massachusetts Avenue, 14 Th Floor, Cambridge, MA

Insiders trading volume in the past year

Spero Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
GSK plc 10%+ Owner $11.7M Nov 7, 2022
Aquilo Capital Management, LLC 10%+ Owner $4.34M Sep 22, 2022
Sath Shukla CEO & President $1.54M -$154K -9.1% Aug 27, 2024
Kamal Hamed Chief Medical Officer $1.08M -$38.5K -3.44% Feb 1, 2024
Ankit Mahadevia Director $1.02M -$95.4K -8.51% Aug 27, 2024
Tamara Joseph Chief Legal Officer $728K -$42.3K -5.49% Feb 1, 2024
Timothy Keutzer Chief Operating Officer $718K -$45.1K -5.91% Aug 27, 2024
Esther Rajavelu Chief Financial Officer and Chief Business Officer $609K Feb 1, 2024
Cristina Larkin Chief Operating Officer $140K Feb 1, 2022
David A. Melnick Chief Medical Officer $138K Feb 1, 2022
Kathleen Tregoning Director $120K May 29, 2024
Milind Deshpande Director $104K May 29, 2024
Frank E. Thomas Director $79.8K May 29, 2024
Cynthia Smith Director $79.8K May 29, 2024
John C. Pottage Jr Director $79.8K May 29, 2024
Scott Thomas Jackson Director $79.8K May 29, 2024
Patrick V.J.J. Vink Director $79.8K May 29, 2024
Jean Francois Formela Director $8.4K Aug 17, 2021
Stephen J. DiPalma Interim Chief Financial Officer Exhibit 24.1 - Power of Attorney Jul 15, 2023

Recent Insider Transactions by Companies or Individuals for Spero Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.